Shire Human Genetic Therapies, Inc. recalls Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, M
Recalled October 2, 2019 · FDA recall D-0036-2020 · Shire Human Genetic Therapies
Hazard
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing · FDA Class I
Units
13,897
Sold at
Product was distributed throughout the United States.
Description
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Product
Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0203-02
Manufacturer(s)
Shire Human Genetic Therapies, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →